Investigation into the frequency of Helicobacter pylori infection with carbon 14 urea breath test in patients with vitiligo

Turkish Journal of Medical Sciences

Volumn 44, Issue 6, 2014, Pages 1051-1054

  Rifaioğlu, Emine Nur ^a   Aydoğan, Füsun ^a   Bülbül Şen, Bilge ^a   Şen, Tuğba ^a   Ekiz, Özlem ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Carbon 14; Helicobacter pylori; Urea breath test; Vitiligo

Indexed keywords

ANTACID AGENT; CARBON 14; CITRIC ACID; CYANOCOBALAMIN; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; SUCRALFATE; THYROID ANTIBODY; THYROTROPIN; CARBON; UREA;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG WITHDRAWAL; FEMALE; HELICOBACTER INFECTION; HUMAN; MALE; PROSPECTIVE STUDY; UREA BREATH TEST; VITILIGO; BREATH ANALYSIS; COMORBIDITY; DIAGNOSTIC USE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MIDDLE AGED; PROCEDURES;

BREATH TESTS; CARBON RADIOISOTOPES; COMORBIDITY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; UREA; VITILIGO;

EID: 84908075504     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: 10.3906/sag-1309-87     Document Type: Article

References (30)

1. Lee B W, Schwartz RA, Hercogova J, Valle Y, Lotti TM. Vitiligo road map. Dermatol Ter 2012; 25: S44–S56.
2. Kruger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol 2012; 51: 1206–1212.
3. Wu J, Zhou M, Wan Y, Xu A. CD8+ T cells from vitiligo perile-sional margins induce autologous melanocyte apoptosis. Mol Med Rep 2013; 7: 237–241.
4. Namazi MR. Neurogenic dysregulation, oxidative stress, autoimmunity, and melanocytorrhagy in vitiligo: can they be interconnected? Pigment Cell Res 2007; 20: 360–363.
5. Lin X, Tian H, Xianmin M. Possible roles of B lymphocyte activating factor of the tumour necrosis factor family in vitiligo autoimmunity. Med Hypotheses 2011; 76: 339–342.
6. Westerhof W, Manini P, Napolitano A, d’Ischia M. The haptenation theory of vitiligo and melanoma rejection: a close-up. Exp Dermatol 2011; 20: 92–96.
7. Metwalley KA, Farghaly HS. Hepatitis C virus infection in a child with autoimmune polyendocrine syndrome type 2: a case report. J Med Case Rep 2012; 6: 221.
8. Akbayir N, Gökdemir G, Mansur T, Sökmen M, Gündüz S, Alkim C, Barutcuoglu B, Erdem L. Is there any relationship between hepatitis C virus and vitiligo? J Clin Gastroenterol 2004; 38: 815–817.
9. Grimes PE, Sevall JS, Vojdani A. Cytomegalovirus DNA identifed in skin biopsy specimens of patients with vitiligo. J Am Acad Dermatol 1996; 35: 21–26.
10. Porras C, Nodora J, Sexton R, Ferreccio C, Jimenez S, Domin-guez RL, Cook P, Anderson G, Morgan DR, Baker LH et al. Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701). Cancer Causes Control 2013; 24: 209–215.
11. Mhaskar RS, Ricardo I, Azliyati A, Laxminarayan R, Amol B, Santosh W, Boo K. Assessment of risk factors of Helicobacter pylori infection and peptic ulcer disease. J Glob Infect Dis 2013; 5: 60–67.
12. Campuzano-Maya G. Cure of alopecia areata afer eradication of Helicobacter pylori: a new association? World J Gastroenterol 2011; 17: 3165–3170.
13. Ersoy O, Ersoy R, Yayar O, Demirci H, Tatlican S. H pylori infection in patients with Behcet’s disease. World J Gastroenterol 2007; 13: 2983–2985.
14. Ben Mahmoud L, Ghozzi H, Hakim A, Sahnoun Z, Zeghal K. Helicobacter pylori associated with chronic urticaria. J Infect Dev Ctries 2011; 5: 596–598.
15. Neri S, Ierna D, D’Amico RA, Giarratano G, Leotta C. Helicobacter pylori and prurigo nodularis. Hepatogastroenterology 1999; 46: 2269–2272.
16. Onsun N, Arda Ulusal H, Su O, Beycan I, Biyik Ozkaya D, Senocak M. Impact of Helicobacter pylori infection on severity of psoriasis and response to treatment. Eur J Dermatol 2012; 22: 117–120.
17. El-Khalawany M, Mahmoud A, Mosbeh AS, Abd Alsalam F, Ghonaim N, Abou-Bakr A. Role of Helicobacter pylori in common rosacea subtypes: a genotypic comparative study of Egyptian patients. J Dermatol 2012; 39: 989–995.
18. Hernando-Harder AC, Booken N, Goerdt S, Singer MV, Harder H. Helicobacter pylori infection and dermatologic diseases. Eur J Dermatol 2009; 19: 431–444.
19. Hercogova J, Schwartz RA, Lotti TM. Classifcation of vitiligo: a challenging endeavor. Dermatol Ter 2012; 25: S10–S16.
20. Özdemir E, Karabacak NI, Değertekin B, Cırak M, Dursun A, Engin D, Ünal S, Ünlü M. Could the simplifed (14)C urea breath test be a new standard in noninvasive diagnosis of Helicobacter pylori infection? Ann Nuc Med 2008; 22: 611–616.
21. Mishra S. Is Helicobacter pylori good or bad? Eur J Clin Microbiol Infect Dis 2013; 32: 301–304.
22. Suzuki H, Franceschi F, Nishizawa T, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection. Helicobacter 2011; 16: S65–S69.
23. Oztürk E, Yeşilova Z, Ilgan S, Arslan N, Erdil A, Celasun B, Ozgüven M, Dağalp K, Ovali O, Bayhan H. A new, practical, low-dose 14C-urea breath test for the diagnosis of Helicobacter pylori infection: clinical validation and comparison with the standard method. Eur J Nucl Med Mol Imaging 2003; 30: 1457–1462.
24. Türkölmez S, Cayir D, Aydoğan F, Korkmaz M. The relationship of Helicobacter pylori positivity with age, sex, and ABO/Rhesus blood groups in patients with gastrointestinal complaints in Turkey. Helicobacter 2007; 12: 244–250.
25. Magen E, Mishal J. Possible beneft from treatment of Helicobacter pylori in antihistamine-resistant chronic urticaria. Clin Exp Dermatol 2013; 38: 7–12.
26. Sadighha A, Shirali R, Zahed GM. Relationship between Helicobacter pylori and chronic urticaria. J Eur Acad Dermatol Venereol 2009; 23: 198–199.
27. Abdel-Hafez HZ, Mahran AM, Hofny ER, Attallah DA, Sayed DS, Rashed HA. Is Helicobacter pylori infection associated with alopecia areata? J Cosmet Dermatol 2009; 8: 52–55.
28. Alkhateeb A, Fain PR, Tody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003; 16: 208–214.
29. Akay BN, Bozkir M, Anadolu Y, Gullu S. Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: Ankara study of 80 patients in Turkey. J Eur Acad Dermatol Venereol 2010; 24: 1144–1150.
30. van Eden W, Koets A, van Kooten P, Prakken B, van der Zee R. Immunopotentiating heat shock proteins: negotiators between innate danger and control of autoimmunity. Vaccine 2003; 21: 897–901.